Cibc World Markets Corp Relay Therapeutics, Inc. Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 11,388 shares of RLAY stock, worth $45,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,388Holding current value
$45,665% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
206Shares Held
157MCall Options Held
192KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$112 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$58 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$42.3 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$37.1 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$29.6 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $482M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...